CD248 and neoplasm: To the best of our knowledge, this is the first study to illustrate the expression pattern of CD248 in UCB and clarify the relationship between the expression of two tumor-associated vascular biomarkers (PSMA and CD248) and the clinicopathological features, prognosis, and survival of patients with UCB systematically.